These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 6233387

  • 1. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME, Nussenzweig V.
    J Exp Med; 1984 Jun 01; 159(6):1669-85. PubMed ID: 6233387
    [Abstract] [Full Text] [Related]

  • 2. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 01; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 3. Complement receptor is an inhibitor of the complement cascade.
    Iida K, Nussenzweig V.
    J Exp Med; 1981 May 01; 153(5):1138-50. PubMed ID: 6910481
    [Abstract] [Full Text] [Related]

  • 4. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 5. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.
    Kinoshita T, Medof ME, Hong K, Nussenzweig V.
    J Exp Med; 1986 Nov 01; 164(5):1377-88. PubMed ID: 2430040
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C, Bradt BM, Nemerow GR, Cooper NR.
    J Exp Med; 1988 Sep 01; 168(3):949-69. PubMed ID: 2844953
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME, Kinoshita T, Nussenzweig V.
    J Exp Med; 1984 Nov 01; 160(5):1558-78. PubMed ID: 6238120
    [Abstract] [Full Text] [Related]

  • 8. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T, Matsumoto M, Nakanishi I, Yasuda R, Seya T.
    J Biochem; 1992 May 01; 111(5):573-8. PubMed ID: 1386357
    [Abstract] [Full Text] [Related]

  • 9. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 01; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 10. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 11. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 13. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 14. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT.
    J Exp Med; 1988 Nov 01; 168(5):1699-717. PubMed ID: 2972794
    [Abstract] [Full Text] [Related]

  • 15. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
    Seya T, Okada M, Nishino H, Atkinson JP.
    J Biochem; 1990 Feb 01; 107(2):310-5. PubMed ID: 2141838
    [Abstract] [Full Text] [Related]

  • 16. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
    Jepsen HH, Teisner B, Svehag SE.
    Scand J Immunol; 1990 Apr 01; 31(4):397-403. PubMed ID: 2139734
    [Abstract] [Full Text] [Related]

  • 17. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME, Iida K, Mold C, Nussenzweig V.
    J Exp Med; 1982 Dec 01; 156(6):1739-54. PubMed ID: 7175439
    [Abstract] [Full Text] [Related]

  • 18. C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytes.
    Mold C, Medof ME.
    Mol Immunol; 1985 May 01; 22(5):507-12. PubMed ID: 3848661
    [Abstract] [Full Text] [Related]

  • 19. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T, Lavoie S, Nussenzweig V.
    J Immunol; 1985 Apr 01; 134(4):2564-70. PubMed ID: 3156184
    [Abstract] [Full Text] [Related]

  • 20. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H, Kinoshita T, Kim YU, Takata-Kozono Y, Tsunasawa S, Sakiyama F, Takeda J, Hong K, Inoue K.
    J Biol Chem; 1990 Aug 25; 265(24):14444-9. PubMed ID: 2387864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.